All Posts Tagged With: "lost to follow up"
Important Considerations in Clinical Research and Pharmacovigilance
Important Considerations in Clinical Research and Pharmacovigilance
With an overall goal in protecting public health, the objective of pharmacovigilance (PV) is to promote the safe clinical use of medicines and prevent adverse drug reactions from clinical investigation throughout post-marketing of a drug. While there are multitudes of factors that affect a PV program, the focus of [...]
Electronic Medical Records Utility in Clinical Trial Conduct
Electronic Medical Records Utility in Clinical Trial Conduct
Patient dropouts and those lost to follow-up (LTFU) pose a major challenge and costly burden in the conduct of clinical trials as each patient represents a valuable source of data. High patient dropout rates are not only costly but pose a risk to the interpretation and validity of [...]
Clinical Trial Conduct: Burden of Patient Dropouts and Patients Lost To Follow-Up
Patient Dropouts / Lost To Follow-Up Implications
In any clinical trial, issues of patient retention, patient dropouts and patients lost to follow-up ( LTFU ) poses a major challenge. Each patient represents a significant amount of time, effort and other resources, so that a high rate of patient dropouts are not only costly but pose a risk to the interpretation and [...]
Addressing Clinical Trial Recruitment and Patient Retention Issues Imposed by HIPAA Step by Step (third of a series)
Patient Retention
Recent reports have indicated that the Health Insurance Portability and Accountability Act (HIPAA) that went into effect in 2003 has adversely affected clinical trial conduct and patient retention by imposing significant time and cost burden and by impeding clinical trial recruiting and patient retention,1 which in turn has deterred patient search efforts–locating patients lost-to-follow-up. [...]
Addressing Clinical Trial Recruitment and Retention Issues Imposed by HIPAA Step by Step (second of a series)
Clinical Trial Recruitment
Recent reports have indicated that the Health Insurance Portability and Accountability Act (HIPAA) that went into effect in 2003 has adversely affected clinical trial conduct by imposing significant time and cost burdens, and by impeding clinical trial recruitment and retention,1 which in turn has deterred finding patients lost-to-follow-up (LTFU). This post will serve [...]
Prevent Lost To Follow-Up With OmniTrace’s Patient Locator Service
Patient Locator
Our OmniTrace patient locator division has located well over five thousand patients who were at one point considered lost to follow-up.
Finding missing people is all we do (well almost). We have located tens of thousands of people including: clinical trial patients, lost friends, military personnel, lost loves, classmates, debtors, dead beat parents, missing heirs, lost family members [...]
Impact Of HIPAA On Clinical Trial Conduct
Clinical Trial Conduct
Assuring full compliance of guidelines mandated by governing authorities is critical to conducting successful clinical trial research and to subsequent product approval. The federal government’s medical privacy rule, the Health Insurance Portability and Accountability Act (HIPAA), that went into effect in 2003 is such a mandate. It has greatly impacted the conduct of [...]
Find Patients Lost To Follow-Up
OmniTrace Corp. - The Patient Search Experts. We maximize clinical trial success by greatly reducing patients Lost To Follow-Up. We find patients and clinical trial participants who become missing anywhere in the world. In addition to our patient locate service, we offer
13Jul2008 | admin | 0 comments | Continued
HIPAA: Clinical Study Conduct When Searching For Patients Lost To Follow-Up
Much information exists about HIPAA–a multifaceted legislation covering the insurance portability and fraud enforcement (accountability) acts. However, the guidance for privacy and security laws are vague, particularly regarding:
Clinical study conduct and searching for patients that have prematurely dropped out and are lost to follow-up
How HIPAA affects long-term follow-up (pharmacovigilance) programs encourage by the FDA for subjects in [...]
FDA Patient Safety News- Preventing Medical Errors: Medical Errors from Misreading Letters and Numbers March 1, 2010
- Recalls and Safety Alerts: Cleviprex Recalled due to Particulates March 1, 2010
- Recalls and Safety Alerts: Don't Use Thermoflect Products with MRI March 1, 2010
- Recalls and Safety Alerts: Safety Precautions for Huber Needles March 1, 2010
- Recalls and Safety Alerts: Valproate Sodium and Birth Defects March 1, 2010
